Veracyte, Inc. (VCYT)
40.47
+0.33
(+0.82%)
USD |
NASDAQ |
Sep 16, 10:11
Veracyte Price : 40.47 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 40.83 | 42.36 | 39.10 | 40.14 | 1.761M |
| Sep 14, 2026 | 41.17 | 41.40 | 40.50 | 41.21 | 1.032M |
| Sep 11, 2026 | 42.61 | 42.66 | 40.79 | 40.87 | 1.002M |
| Sep 10, 2026 | 43.18 | 43.78 | 41.64 | 42.03 | 849422.0 |
| Sep 09, 2026 | 42.79 | 44.20 | 42.38 | 43.86 | 1.450M |
| Sep 08, 2026 | 41.81 | 43.28 | 41.57 | 42.45 | 962029.0 |
| Sep 04, 2026 | 44.21 | 44.81 | 42.43 | 42.53 | 992183.0 |
| Sep 03, 2026 | 45.36 | 45.99 | 44.12 | 44.67 | 673667.0 |
| Sep 02, 2026 | 43.51 | 45.65 | 43.48 | 44.88 | 1.372M |
| Sep 01, 2026 | 42.97 | 43.74 | 42.28 | 43.43 | 873012.0 |
| Aug 31, 2026 | 42.33 | 43.34 | 41.60 | 43.19 | 1.472M |
| Aug 28, 2026 | 45.20 | 45.55 | 43.32 | 43.34 | 1.684M |
| Aug 27, 2026 | 44.20 | 45.50 | 44.19 | 45.25 | 1.329M |
| Aug 26, 2026 | 43.78 | 44.52 | 43.25 | 44.29 | 2.181M |
| Aug 25, 2026 | 42.01 | 44.10 | 41.80 | 44.04 | 1.155M |
| Aug 24, 2026 | 42.00 | 42.07 | 41.02 | 41.47 | 1.165M |
| Aug 21, 2026 | 42.18 | 42.54 | 41.10 | 42.31 | 1.005M |
| Aug 20, 2026 | 41.67 | 42.44 | 41.05 | 41.79 | 980364.0 |
| Aug 19, 2026 | 41.92 | 42.52 | 40.10 | 42.19 | 1.762M |
| Aug 18, 2026 | 41.80 | 42.35 | 40.35 | 40.68 | 1.144M |
| Aug 17, 2026 | 40.96 | 42.50 | 40.96 | 42.08 | 1.574M |
| Aug 14, 2026 | 42.54 | 43.12 | 41.00 | 41.25 | 1.669M |
| Aug 13, 2026 | 45.23 | 45.23 | 42.51 | 42.60 | 1.455M |
| Aug 12, 2026 | 46.54 | 46.76 | 44.28 | 44.68 | 874116.0 |
| Aug 11, 2026 | 46.07 | 46.67 | 45.72 | 46.41 | 551006.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Teleflex, Inc. | 129.08 |
| West Pharmaceutical Services, Inc. | 363.83 |
| Globus Medical, Inc. | 75.46 |
| Illumina, Inc. | 226.02 |
| Twist Bioscience Corp. | 145.93 |
Price Related Metrics
| PE Ratio | 28.72 |
| PS Ratio | 5.842 |
| PEG Ratio | 0.0887 |
| Price to Book Value | 2.343 |
| Price to Free Cash Flow | 19.78 |
| Earnings Yield | 3.48% |
| Market Cap | 3.252B |
| PEGY Ratio | 0.0887 |
| Operating PE Ratio | 33.92 |
| Normalized PE Ratio | 31.37 |